News - sildenafil

Filter

Current filters:

sildenafil

Popular Filters

Actelion says COMPASS-2 bosentan study fails primary endpoint

Actelion says COMPASS-2 bosentan study fails primary endpoint

17-03-2014

Europe’s largest biotech company Actelion has announced disappointing results of COMPASS-2, a Phase…

ActelionBiotechnologybosentanPfizerResearchRespiratory and PulmonarysildenafilTracleer

Teva and Actavis debut generic Viagra in Europe

24-06-2013

The patent on Viagra (sildenafil) expired last Friday (June 21) in the UK and some other European countries,…

ActavisEuropeGenericsMarkets & MarketingMen's HealthReproductivesildenafilTeva Pharmaceutical IndustriesViagra

New Zealand updates on Tracleer and sildenafil listing

21-11-2012

New Zealand's Pharmaceutical Management Agency PHARMAC has announced the approval of an agreement with…

ActelionArrow PharmaceuticalsAsia-PacificPharmaceuticalPricingRegulationRespiratory and PulmonarysildenafilTracleer

FDA warns against use of Pfizer's Revatio in children with PAH

02-09-2012

The US Food and Drug Administration is recommending that Revatio (sildenafil), marketed by US drugs behemoth…

North AmericaPfizerPharmaceuticalRegulationRespiratory and PulmonaryRevatiosildenafil

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top